EUCTR2020-003987-22-DE进行中（未招募）1 期
ORACLE: A long-term follow-up study to evaluate the safety of GT005 in participants with geographic atrophy, secondary to age-related macular degeneration treated in a Gyroscope-sponsored antecedent study. - ORACLE
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 225
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Able and willing to give written informed consent
- •2. Received GT005 in an antecedent study, GT005-01 (FOCUS, NCT03846193), GT005-02 (EXPLORE, NCT04437368 and GT005-03 (HORIZON, NCT04566445)
- •3. Willing to attend study visits and complete the study procedures.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 23
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 202
排除标准
- •Not Applicable.
研究者
相似试验
招募中
1 期
Study to evaluate the long term safety of GT005 in participants having macular degeneration that led to geographic atrophy in their eyes and that have been previously treated in a prior Gyroscope study using the same product.Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) in participants already treated with GT005 in the GT005-02 (EXPLORE) and GT005-03 (HORIZON) antecedent studies.MedDRA version: 20.0Level: LLTClassification code 10075719Term: Atrophic age-related macular degenerationSystem Organ Class: 100000004853EUCTR2020-003987-22-NLGyroscope Therapeutics Ltd.200
进行中（未招募）
1 期
Study to evaluate the long term safety of GT005 in participants having macular degeneration that led to geographic atrophy in their eyes and that have been previously treated in a prior Gyroscope study using the same product.Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) in participants already treated with GT005 in the GT005-02 (EXPLORE) and GT005-03 (HORIZON) antecedent studies.MedDRA version: 20.0Level: LLTClassification code 10075719Term: Atrophic age-related macular degenerationSystem Organ Class: 100000004853EUCTR2020-003987-22-ESGyroscope Therapeutics Ltd.200
撤回
2 期
ORACLE: A long-term follow-up study to evaluate the safety and durability of GT005 in participants with geographic atrophy, secondary to age-related macular degeneration treated in a Gyroscope-sponsored antecedent study.NL-OMON56154Gyroscope Therapeutics Ltd.15
进行中（未招募）
1 期
Study to evaluate the long term safety of GT005 in participants having macular degeneration that led to geographic atrophy in their eyes and that have been previously treated in a prior Gyroscope study using the same product.Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) in participants already treated with GT005 in the GT005-02 (EXPLORE) and GT005-03 (HORIZON) antecedent studies.MedDRA version: 20.0Level: LLTClassification code 10075719Term: Atrophic age-related macular degenerationSystem Organ Class: 100000004853EUCTR2020-003987-22-IEGyroscope Therapeutics Ltd.300
进行中（未招募）
1 期
Study to evaluate the long-term safety of GT005 in participants having macular degeneration that led to geographic atrophy in their eyes and that have been previously treated in a prior Gyroscope study using the same product.Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) in participants already treated with GT005 in the previous studies GT005-01 (FOCUS), GT005-02 (EXPLORE) and GT005-03 (HORIZON).MedDRA version: 20.0Level: LLTClassification code: 10075719Term: Atrophic age-related macular degeneration Class: 10015919CTIS2024-510946-15-00Gyroscope Therapeutics Limited163